ern_skin, Author at ERN Skin

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement

ern_skin2024-09-20T14:52:30+02:00

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement PMID: 37755725 DOI: 10.1001/jamadermatol.2023.3282 [...]

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statementern_skin2024-09-20T14:52:30+02:00

Global consensus process to establish a core data set for hidradenitis suppurativa registries

Global consensus process to establish a core data set for hidradenitis suppurativa registries

ern_skin2024-09-20T14:48:50+02:00

Global consensus process to establish a core data set for hidradenitis suppurativa registries PMID: 37976235 DOI: 10.1093/bjd/ljad454

Global consensus process to establish a core data set for hidradenitis suppurativa registriesern_skin2024-09-20T14:48:50+02:00

Viewpoint on the evaluation of severity and treatment effects in mild hidradenitis suppurativa: the cumulative IHS4 (IHS4-C)

Viewpoint on the evaluation of severity and treatment effects in mild hidradenitis suppurativa: the cumulative IHS4 (IHS4-C)

ern_skin2024-09-20T14:45:14+02:00

Viewpoint on the evaluation of severity and treatment effects in mild hidradenitis suppurativa: the cumulative IHS4 (IHS4-C) PMID: 38118429 DOI: 10.1159/000535867

Viewpoint on the evaluation of severity and treatment effects in mild hidradenitis suppurativa: the cumulative IHS4 (IHS4-C)ern_skin2024-09-20T14:45:14+02:00

Cardiomyopathy in recessive dystrophic epidermolysis bullosa (RDEB)

ern_skin2024-03-22T15:06:39+01:00

6_CardiomyopathyInRDEB_MB_24022023

Cardiomyopathy in recessive dystrophic epidermolysis bullosa (RDEB)ern_skin2024-03-22T15:06:39+01:00

Practical management of epidermolysis bullosa in the newborn: consensus statement from the European Reference Network for Rare Skin Diseases

ern_skin2024-03-22T15:05:08+01:00

5_ManagementNewborn&InfantsWithEB_MEH_240202023

Practical management of epidermolysis bullosa in the newborn: consensus statement from the European Reference Network for Rare Skin Diseasesern_skin2024-03-22T15:05:08+01:00

Dental care pathways for patients with epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases

ern_skin2024-03-22T15:03:37+01:00

4_Dental Pathways_Guidelines_CH_24022023

Dental care pathways for patients with epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseasesern_skin2024-03-22T15:03:37+01:00

Inflammatory mediators in EB

ern_skin2024-03-22T15:01:47+01:00

3_RDEB_ClinicalSeverityScore_ChB_CH_ERN_EB_2402023

Inflammatory mediators in EBern_skin2024-03-22T15:01:47+01:00

Inflammatory mediators in EB

ern_skin2024-03-22T14:53:47+01:00

2_InflammatorySignatures-inEB_ScopingReview_ML_24022023

Inflammatory mediators in EBern_skin2024-03-22T14:53:47+01:00

Epidermolysis bullosa and oral hygiene

ern_skin2024-03-22T14:35:51+01:00

Messages to take home Produced by the Ospedale pediatrico Bambino Gesù, Rome, Italy Validated by The ERN-Skin Epidermolysis Bullosa Thematic Group [...]

Epidermolysis bullosa and oral hygieneern_skin2024-03-22T14:35:51+01:00

Epidermolysis bullosa and breastfeeding

ern_skin2024-03-22T14:34:53+01:00

Messages to take home Produced by the Ospedale pediatrico Bambino Gesù, Rome, Italy Validated by The ERN-Skin Epidermolysis Bullosa Thematic Group [...]

Epidermolysis bullosa and breastfeedingern_skin2024-03-22T14:34:53+01:00

About ern_skin